Inhibition of miR-1193 leads to synthetic lethality in glioblastoma multiforme cells deficient of DNA-PKcs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of miR-1193 leads to synthetic lethality in glioblastoma multiforme cells deficient of DNA-PKcs
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 7, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-30
DOI
10.1038/s41419-020-02812-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets
- (2019) Kristen E. Mengwasser et al. MOLECULAR CELL
- Synergistic lethality between BRCA1 and H3K9me2 loss reflects satellite derepression
- (2019) Jan Padeken et al. GENES & DEVELOPMENT
- FEN1 mediates miR-200a methylation and promotes breast cancer cell growth via MET and EGFR signaling
- (2019) Xue Zeng et al. FASEB JOURNAL
- Association between the flap endonuclease 1 gene polymorphisms and cancer susceptibility: An updated meta‐analysis
- (2019) Abdolkarim Moazeni‐Roodi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Enhanced activity of variant DNA polymerase β (D160G) contributes to cisplatin therapy by impeding the efficiency of NER
- (2019) Meina Wang et al. MOLECULAR CANCER RESEARCH
- ATM in DNA repair in cancer
- (2019) Mei Hua Jin et al. PHARMACOLOGY & THERAPEUTICS
- Synthetic lethality as an engine for cancer drug target discovery
- (2019) Alan Huang et al. NATURE REVIEWS DRUG DISCOVERY
- FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells
- (2019) Jin‐Li Li et al. Cancer Medicine
- High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement
- (2019) Bushan Xie et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
- (2018) Chaoyang Sun et al. CANCER CELL
- The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells GrownIn Vitroand as Orthotopic Xenografts
- (2018) Cindy R. Timme et al. MOLECULAR CANCER THERAPEUTICS
- ATR-Chk1 activation mitigates replication stress caused by mismatch repair-dependent processing of DNA damage
- (2018) Dipika Gupta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
- (2018) Ilaria Plantamura et al. Frontiers in Oncology
- Roles for the Rad27 Flap Endonuclease in Mitochondrial Mutagenesis and Double-Strand Break Repair inSaccharomyces cerevisiae
- (2017) Prabha Nagarajan et al. GENETICS
- Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer
- (2017) Ana Alcaraz-Sanabria et al. MOLECULAR CANCER THERAPEUTICS
- Synthetic lethality and cancer
- (2017) Nigel J. O'Neil et al. NATURE REVIEWS GENETICS
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Roles for the Rad27 Flap Endonuclease in Mitochondrial Mutagenesis and Double-Strand Break Repair inSaccharomyces cerevisiae
- (2017) Prabha Nagarajan et al. GENETICS
- Destabilized SMC5/6 complex leads to chromosome breakage syndrome with severe lung disease
- (2016) Saskia N. van der Crabben et al. JOURNAL OF CLINICAL INVESTIGATION
- Replication protein A as a major eukaryotic single-stranded DNA-binding protein and its role in DNA repair
- (2016) Y. S. Krasikova et al. MOLECULAR BIOLOGY
- The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation
- (2016) H Sun et al. ONCOGENE
- Repair Pathway Choices and Consequences at the Double-Strand Break
- (2016) Raphael Ceccaldi et al. TRENDS IN CELL BIOLOGY
- microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13
- (2016) Han Han et al. Oncotarget
- Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
- (2016) Kumar Sanjiv et al. Cell Reports
- miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3B
- (2015) Hui Xu et al. NEUROSCIENCE LETTERS
- Homologous Recombination Is a Primary Pathway to Repair DNA Double-Strand Breaks Generated during DNA Rereplication
- (2014) Lan N. Truong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of miRNA modulators to PARP inhibitor response
- (2013) Sari Neijenhuis et al. DNA REPAIR
- Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells
- (2013) L. N. Truong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential of the Synthetic Lethality Principle
- (2013) S. M. B. Nijman et al. SCIENCE
- Therapeutic Targeting of a Robust Non-Oncogene Addiction to PRKDC in ATM-Defective Tumors
- (2013) A. Riabinska et al. Science Translational Medicine
- Emerging insights into the molecular and cellular basis of glioblastoma
- (2012) G. P. Dunn et al. GENES & DEVELOPMENT
- Functional FEN1 genetic variants and haplotypes are associated with glioma risk
- (2012) Yi-Dong Chen et al. JOURNAL OF NEURO-ONCOLOGY
- Sequential Posttranslational Modifications Program FEN1 Degradation during Cell-Cycle Progression
- (2012) Zhigang Guo et al. MOLECULAR CELL
- Synthetic lethality between Rb, p53 and Dicer or miR-17–92 in retinal progenitors suppresses retinoblastoma formation
- (2012) David Nittner et al. NATURE CELL BIOLOGY
- Glioblastoma: From Molecular Pathology to Targeted Treatment
- (2011) Timothy F. Cloughesy et al. Annual Review of Pathology-Mechanisms of Disease
- MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications
- (2011) Jiri Sana et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J
- (2010) Wooi Loon Ng et al. DNA REPAIR
- Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
- (2009) H Christian Reinhardt et al. CURRENT OPINION IN CELL BIOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
- (2009) Aimee L. Jackson et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNAs in diseases and drug response
- (2008) M GAROFALO et al. CURRENT OPINION IN PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now